Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

BACKGROUND: Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Lancet
المؤلفون الرئيسيون: Parker, Chris C, Clarke, Noel W, Cook, Adrian D, Kynaston, Howard, Catton, Charles N, Cross, William R, Petersen, Peter M, Persad, Rajendra A, Saad, Fred, Bower, Lorna C, Logue, John, Payne, Heather, Forcat, Silvia, Goldstein, Cindy, Murphy, Claire, Anderson, Juliette, Barkati, Maroie, Bottomley, David M, Branagan, Jennifer, Choudhury, Ananya, Chung, Peter W M, Cogley, Lyn, Goh, Chee L, Hoskin, Peter, Khoo, Vincent, Malone, Shawn C, Masters, Lindsey, Morris, Stephen L, Nabid, Abdenour, Ong, Aldrich D, Raman, Rakesh, Tarver, Kathryn L, Tree, Alison C, Worlding, Jane, Wylie, James P, Zarkar, Anjali M, Parulekar, Wendy R, Parmar, Mahesh K B, Sydes, Matthew R
التنسيق: Artigo
اللغة:Inglês
منشور في: 2024
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616360/
https://ncbi.nlm.nih.gov/pubmed/38763154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(24)00548-8
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة